Filing Details

Accession Number:
0001567619-21-011569
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-02 19:23:29
Reporting Period:
2021-05-28
Accepted Time:
2021-06-02 19:23:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611311 P. David Rosenbaum C/O Ardelyx, Inc.
34175 Ardenwood Blvd, Suite 200
Fremont CA 94555
Chief Development Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-05-28 3,062 $7.22 26,750 No 4 S Indirect By Wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Wife
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 77,592 Indirect Family Trust
Common Stock 159,435 Direct
Footnotes
  1. The transaction was executed in multiple trades in prices ranging from $7.215 to $7.221, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  2. The shares are directly held by the Reporting Person's wife.
  3. The shares are directly held by David Paul Rosenbaum and Susan Edelstein Rosenbaum, Trustees of the David Paul Rosenbaum Family Trust.